Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03922204 |
| Title | A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merus N.V. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moores Cancer Centre | La Jolla | California | 92093-0987 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| University Hospital Antwerp | Antwerp | Edegem | 2650 | Belgium | Details | |
| Universitair Ziekenhuis Gent | Gent | 9000 | Belgium | Details | ||
| Netherlands Cancer Institute | Amsterdam | 1066CX | Netherlands | Details | ||
| Hospital Universitario Fundarcion Jimenez Diaz | Madrid | 28040 EP | Spain | Details | ||
| Clinica Universidad de Navarra | Pamplona | 31008 EP | Spain | Details |